Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HAM Ciclosporin Study
2006-002031-24Phase 2Completed
- Sponsor
- Imperial College London
- Start
- May 2006
- Modality
- Small Molecules, Peptides
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of cyclosporine in HTLV-1-associated myelopathy (HAM), sponsored by Imperial College London. Primary endpoint: Incidence of clinical failure at 48 weeks. Started May 2006; status: completed.
02
Drugs
cyclosporine
03
Conditions
HTLV-1-associated myelopathy (HAM)
Beyond the preview
Go deeper on 2006-002031-24.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-002031-24.